Member

$SYRS is positioning to launch. Insiders beefing up ownership. Funds beefing up ownership. Next data printout will launch this stock.

$4.00 dollars is the new floor. $SYRS is positioned to launch with next data printout. Very exciting. If feds learn to stop handing out free money, inflation will comedown and the markets will start functioning normally once again. “Regarding the Great Depression, … we did it. We’re very sorry. … We won’t do it again.”
—Ben Bernanke.

$SYRS is positioned to launch.

Syros stock rises as tamibarotene gets FDA fast track status for rare blood cancer

file:///var/mobile/Library/SMS/Attachments/fc/12/92991708-8E42-49C9-AEBE-0D7F7C3BDBC5/IMG_5828.JPG

Read analyst reports on $SYRS. $34.20 or better. I think this will be a 6 dollar stock by mid February 2023. They additional data coming out from one of their studies.

Now is a good time to buy $SYRS. ANALYSTS ARE SUPPORTING $34.20 or better share price

$SYRS

(2023)
Consensus Analyst Rating
Based on 5 Analyst Ratings
Consensus Analyst Price Target
$34.20
^ 684.40% Upside
High Prediction
Average Prediction
Low Prediction
$100.00
$34.20
$15.00

As $SYRS approaches another successful data printout and with runway to 2025 and the support of Flagship (founded by founder of Moderna) Syros should break 5 today and cruise to 10 dollars by mid March